| Literature DB >> 27936083 |
Päivi Kolu1, Jani Raitanen1,2, Jatta Puhkala1, Pipsa Tuominen1, Pauliina Husu1, Riitta Luoto2.
Abstract
There is a link between the pregnancy and its long-term influence on health and susceptibility to future chronic disease both in mother and offspring. The objective was to determine whether individual counseling on physical activity and diet and weight gain at five antenatal visits can prevent type 2 diabetes mellitus (T2DM) and overweight or improve glycemic parameters, among all at-risk-mothers and their children. Another objective was to evaluate whether gestational lifestyle intervention was cost-effective as measured with mother's sickness absence and quality-adjusted life years (QALY). This study was a seven-year follow-up study for women, who were enrolled to the antenatal cluster-randomized controlled trial (RCT). Analysis of the outcome included all women whose outcome was available, in addition with subgroup analysis including women adherent to all lifestyle aims. A total of 173 women with their children participated to the study, representing 43% (173/399) of the women who finished the original RCT. Main outcome measures were: T2DM based on medication use or fasting blood glucose or oral glucose tolerance test (OGTT), body mass index (BMI), glycosylated hemoglobin (HbA1c). None of the women were diagnosed to have T2DM. HbA1c or fasting blood glucose differences were not found among mothers or children. Differences in BMI were non-significant among mothers (Intervention 27.3, Usual care 28.1 kg/m2, p = 0.33) and children (I 21.3 vs U 22.5 kg/m2, p = 0.07). Children's BMI was significantly lower among adherent group (I 20.5 vs U 22.5, p = 0.04). The mean total cost per person was 30.6% lower in the intervention group than in the usual care group (I €2,944 vs. U €4,243; p = 0.74). Intervention was cost-effective in terms of sickness absence but not in QALY gained i.e. if society is willing to pay additional €100 per one avoided sickness absence day; there is a 90% probability of the intervention arm to be cost-effective. Long-term effectiveness of antenatal lifestyle counseling was not shown, in spite of possible effect on children's BMI. Cost-effectiveness of the intervention in terms of sickness absence may have larger societal impact.Entities:
Mesh:
Year: 2016 PMID: 27936083 PMCID: PMC5147978 DOI: 10.1371/journal.pone.0167759
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flow diagram of the cluster-randomized trial from enrollment till 7 year follow-up.
Characteristics (mean ± SD or frequency and percentage).
| Intervention group n = 85 | Usual care group n = 88 | p | Missing (Intervention/Control) | |
|---|---|---|---|---|
| Age | 37.7 (4.5) | 38.1 (4.9) | 0.66 | - |
| Education level | 0.23 | 2/0 | ||
| Low | 25 (30.1%) | 25 (28.4%) | ||
| Medium | 28 (33.7%) | 40 (45.5%) | ||
| High | 30 (36.1%) | 23 (26.1%) | ||
| Smoking | 0.88 | 5/3 | ||
| No | 73 (91.3%) | 77 (90.6%) | ||
| Occasionally / daily | 7 (8.7%) | 8 (9.4%) | ||
| Number of children | 0.42 | 6/4 | ||
| 1 | 8 (10.1%) | 12 (14.3%) | ||
| ≥2 | 71 (89.9%) | 72 (85.7%) | ||
| Work | 0.68 | 5/3 | ||
| Full- or part-time work | 57 (71.3%) | 63 (74.1%) | ||
| Other (e.g. unemployed) | 23 (28.7%) | 22 (25.9%) | ||
| Gestational diabetes during pregnancy | 5 (6.3%) | 4 (4.8%) | 1 |
Outcome measures for effectiveness and cost-effectiveness during gestation and 7-year follow-up.
| Outcomes | 8–12 week gestation | 7 year follow up | Change from 8–12 week to 7 year follow up | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean (SD) | p-value | Mean (SD) | p-value | Mean (SD) | p-value | Missing | ||||
| InterventionGroup (n = 85) | Usual Care Group (n = 88) | Difference between groups | Intervention Group (n = 85) | Usual Care Group (n = 88) | Difference between groups | Intervention Group (n = 85) | Usual Care Group (n = 88) | Difference between groups | (Intervention/Control) | |
| 4.90 (0.22) | 4.79 (0.29) | 0.01 | 5.15 (0.48) | 5.20 (0.42) | 0.57 | 0.25 (0.49) | 0.41 (0.39) | 0.15 | 16/22 | |
| 1-h OGTT | 6.61 (1.59) | 6.15 (1.39) | 0.09 | 6.24 (1.94) | 5.99 (1.53) | 0.43 | -0.37 (1.96) | -0.16 (1.59) | 0.91 | 21/26 |
| 2-h OGTT | 5.32 (1.04) | 5.18 (0.82) | 0.39 | 5.65 (1.40) | 5.33 (0.99) | 0.14 | 0.33 (1.58) | 0.15 (0.94) | 0.20 | 21/26 |
| 34.6 (2.33) | 34.8 (2.43) | 0.76 | 15/12 | |||||||
| 11.8 (6.94) | 12.1 (8.02) | 0.61 | 8.45 (4.25) | 9.67 (6.67) | 0.50 | -3.39 (6.91) | -2.46 (9.72) | 0.91 | 21/10 | |
| Weight (kg) | 71.4 (16.2) | 73.3 (11.0) | 0.39 | 75.6 (17.3) | 76.9 (13.1) | 0.56 | 4.13 (6.56) | 3.67 (7.59) | 0.69 | 2/1 |
| Body mass index | 25.8 (4.95) | 26.7 (4.13) | 0.22 | 27.3 (5.48) | 28.1 (5.08) | 0.33 | 1.50 (2.41) | 1.42 (3.09) | 0.88 | 3/1 |
| Waist circumference (cm) | 89.9 (13.0) | 90.9 (12.8) | 0.63 | 11/13 | ||||||
| At least moderate (minutes/day) | 39 (0.28) | 37 (0.33) | 0.72 | 14/15 | ||||||
| Total (h+ minutes/day) | 4.41 (1.30) | 4.54 (1.12) | 0.30 | 14/15 | ||||||
| 0.95 (0.04) | 0.95 (0.05) | 0.61 | 0.94 (0.06) | 0.93 (0.06) | 0.30 | -0.01 (0.06) | -0.02 (0.05) | 0.13 | 5/3 | |
| 21.3 (3.79) | 22.5 (4.31) | 0.07 | 11/19 | |||||||
| 34.4 (2.04) | 34.8 (2.32) | 0.31 | 32/36 | |||||||
| 4.94 (0.49) | 4.93 (0.41) | 0.81 | 32/37 | |||||||
1 Linear regression models
2 Adjusted for baseline (8–12 week gestation)
Annual mean health care costs (mean and SD) and productivity costs.
| Intervention group ( | Control group ( | |||||
|---|---|---|---|---|---|---|
| Unit cost (EUR) | Number of units | Mean cost (EUR) | Number of units | Mean cost (EUR) | ||
| Occupational health care doctor | 78/ visit | 1.5 (2.2) | 113.5 | 1.7 (4.5) | 131.4 | 0.76 |
| Primary care doctor | 117/ visit | 0.9 (1.5) | 105.6 | 1.3 (1.5) | 148.7 | 0.013 |
| Special health care doctor | 310/ visit | 0.6 (1.0) | 185.8 | 0.9 (2.2) | 284.6 | 0.86 |
| Registered nurse in primary care | 51/ visit | 0.4 (1.5) | 21.1 | 0.4 (1.2) | 18.6 | 0.21 |
| Public health nurse in occupational health | 42/ visit | 0.5 (0.9) | 19.0 | 0.5 (0.9) | 19.0 | 0.87 |
| Public health nurse in maternity clinic | 58/ visit | 0.9 (2.9) | 52.6 | 0.5 (1.7) | 26.9 | 0.56 |
| Public health nurse in child health clinic | 53/ visit | 0.6 (1.6) | 32.0 | 0.4 (0.9) | 21.0 | 0.95 |
| Public health nurse in family planning clinic | 51/ visit | 0.03 (0.16) | 1.3 | 0.12 (0.62) | 6.1 | 0.065 |
| Physiotherapist | 60/ visit | 0.8 (2.5) | 45.1 | 0.5 (1.7) | 31.0 | 0.66 |
| Medication | 268.2 | 238.6 | 0.17 | |||
| Inpatient days in primary care | 250/ day | 0.06 (0.40) | 15.6 | - | 0.3 | 0.73 |
| Inpatient days in special health care | 820/ day | 0.11 (0.50) | 92.3 | 0.31 (1.18) | 246.8 | 0.12 |
| 0.33 | ||||||
| Absence from work (€3,534/month) | 193/day | 10.3 (18.3) | 1,992 | 16.1 (32.7) | 3,070 | 0.93 |
| 0.74 | ||||||
Mean costs and effect differences (95% CI) between the intervention and usual care group and the sensitivity analysis, including incremental cost-effectiveness ratios and cost-effectiveness plane distributions.
| Sample size | Costs (EUR) | Effects | ICER | Distribution on CE plane (%) | |||||
|---|---|---|---|---|---|---|---|---|---|
| Intervention group | Control group | Δ of intervention—usual care (95% CI) | Δ of intervention—usual care (95% CI) | NE | SE | SW | NW | ||
| Absence from work | 80 | 83 | -1,356 (-3,862 to 248) | 5.82 (-1.26 to 15.7) | -233 | 2.1 | 90.6 | 1.7 | 5.6 |
| QALYs | 80 | 85 | -1,300 (-3,600 to 224) | 0.24 (-0.61 to 0.96) | -5,386 | 4.9 | 68.2 | 24.4 | 2.5 |
| Absence from work | 80 | 83 | -233 (-978 to 306) | 5.82 (-1.26 to 15.7) | -40 | 21.6 | 71.1 | 4.0 | 3.3 |
| QALYs | 80 | 85 | -221 (-931 to 286) | 0.24 (-0.61 to 0.96) | -917 | 17.3 | 55.8 | 19.9 | 7.0 |
| Absence from work | 80 | 82 | -1,394 (-4,002 to 97) | 6.00 (-0.52 to 16.2) | -232 | 1.6 | 91.8 | 1.6 | 5.0 |
| QALYs | 80 | 82 | -1,394 (-4,002 to 97) | 0.20 (-0.65 to 0.91) | -6,949 | 4.2 | 65.8 | 27.6 | 2.4 |
* 95% CI: 95% confidence interval (‘bias-corrected and accelerated’ method), NE: north-east, SE: south-east, SW: south-west, NW: north-west.
Fig 2Cost-effectiveness plane and acceptability curve for absence from work.
Fig 3Cost-effectiveness plane and acceptability curve for QALY gained.